Answers are grounded in this paper and cite their sources.
The pursuit of sustainable, high-efficacy antioxidants from botanical and marine resources has necessitated a shift toward advanced metabolic profiling and green extraction technologies. This paper comprehensively evaluates more than 100 high-impact research studies from 2020 through early 2026, focusing on the interplay between extraction physics, tissue-level localization, and pharmacological outcomes. The quantitative metrics presented herein reflect the peak capabilities and maximum/optimum ranges established within the current scope of this reviewed literature; as green extraction technologies and optimization protocols continue to rapidly evolve, future updated literature is expected to surpass these benchmarks and deliver even higher quantitative results. Findings demonstrate that the use of polar organic solvents, such as ethanol and methanol, consistently maximizes bioactive recovery, with total phenolic contents reaching ranges between 300 and 1,000 mg GAE/g, while flavonoid concentrations in specific leaf tissues can exceed 1,000 mg QE/g. Furthermore, the valorization of agro-industrial by-products, specifically the peels and seeds of various species, reveals a higher nutrient density than corresponding pulps, often achieving radical inhibition rates as high as 90%. Technological advancements, including supercritical fluid extraction and cold plasma-assisted methods, are shown to retain up to three times more bioactive integrity compared to traditional drying techniques. Mechanistic insights derived from molecular docking simulations indicate that key secondary metabolites possess stable binding affinities ranging from -7 to -9 kcal/mol against targets for metabolic and inflammatory disorders. Biological and culinary processing, such as fermentation and steaming, are further identified as critical variables in enhancing compound bioavailability. In conclusion, the strategic integration of green chemistry, artificial intelligence, and waste repurposing is essential for standardizing natural antioxidants. Future research must prioritize in vivo validation and the exploration of microbiome-phytochemical interactions to fully realize the therapeutic potential of these natural agents within a circular economy framework.
No takes yet. Share an insight, caveat, or question.
Mehmet Melikoğlu (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: